Literature DB >> 31408339

Discovery of N-Substituted 3-Amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic Acids as Highly Potent Third-Generation Inhibitors of Human Arginase I and II.

Michael C Van Zandt1, G Erik Jagdmann1, Darren L Whitehouse1, Minkoo Ji1, Jennifer Savoy1, Olga Potapova2, Alexandra Cousido-Siah3, Andre Mitschler3, Eduardo I Howard4, Anna Marie Pyle2, Alberto D Podjarny3.   

Abstract

Recent efforts to identify new highly potent arginase inhibitors have resulted in the discovery of a novel family of (3R,4S)-3-amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid analogues with up to a 1000-fold increase in potency relative to the current standards, 2-amino-6-boronohexanoic acid (ABH) and N-hydroxy-nor-l-arginine (nor-NOHA). The lead candidate, with an N-2-amino-3-phenylpropyl substituent (NED-3238), example 43, inhibits arginase I and II with IC50 values of 1.3 and 8.1 nM, respectively. Herein, we report the design, synthesis, and structure-activity relationships for this novel series of inhibitors, along with X-ray crystallographic data for selected examples bound to human arginase II.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31408339     DOI: 10.1021/acs.jmedchem.9b00931

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.

Authors:  J Muller; B Cardey; A Zedet; C Desingle; M Grzybowski; P Pomper; S Foley; D Harakat; C Ramseyer; C Girard; M Pudlo
Journal:  RSC Med Chem       Date:  2020-04-17

2.  Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy.

Authors:  Matthew J Mitcheltree; Derun Li; Abdelghani Achab; Adam Beard; Kalyan Chakravarthy; Mangeng Cheng; Hyelim Cho; Padmanabhan Eangoor; Peter Fan; Symon Gathiaka; Hai-Young Kim; Charles A Lesburg; Thomas W Lyons; Theodore A Martinot; J Richard Miller; Spencer McMinn; Jennifer O'Neil; Anandan Palani; Rachel L Palte; Josep Saurí; David L Sloman; Hongjun Zhang; Jared N Cumming; Christian Fischer
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

3.  Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.

Authors:  Roman Blaszczyk; Joanna Brzezinska; Barbara Dymek; Paulina S Stanczak; Marcin Mazurkiewicz; Jacek Olczak; Julita Nowicka; Karolina Dzwonek; Agnieszka Zagozdzon; Jakub Golab; Adam Golebiowski
Journal:  ACS Med Chem Lett       Date:  2020-03-13       Impact factor: 4.345

4.  Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158.

Authors:  Yvonne Grobben; Joost C M Uitdehaag; Nicole Willemsen-Seegers; Werner W A Tabak; Jos de Man; Rogier C Buijsman; Guido J R Zaman
Journal:  J Struct Biol X       Date:  2019-11-26

Review 5.  Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective.

Authors:  Gonçalo S Clemente; Aren van Waarde; Inês F Antunes; Alexander Dömling; Philip H Elsinga
Journal:  Int J Mol Sci       Date:  2020-07-25       Impact factor: 5.923

Review 6.  Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.

Authors:  Zhuozhuo Li; Liwei Wang; Yuanyuan Ren; Yaoyao Huang; Wenxuan Liu; Ziwei Lv; Lu Qian; Yi Yu; Yuyan Xiong
Journal:  Cell Death Discov       Date:  2022-10-08

7.  Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action.

Authors:  Rachel L Palte; Veronica Juan; Yacob Gomez-Llorente; Marc Andre Bailly; Kalyan Chakravarthy; Xun Chen; Daniel Cipriano; Laurence Fayadat-Dilman; Symon Gathiaka; Heiko Greb; Brian Hall; Mas Handa; Mark Hsieh; Esther Kofman; Heping Lin; J Richard Miller; Nhung Nguyen; Jennifer O'Neil; Hussam Shaheen; Eric Sterner; Corey Strickland; Angie Sun; Shane Taremi; Giovanna Scapin
Journal:  Commun Biol       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.